155 related articles for article (PubMed ID: 24898456)
21. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
[TBL] [Abstract][Full Text] [Related]
22. Practical issues that should be considered when planning the implementation of pathogen reduction technology for plateletpheresis.
Jimenez-Marco T; Mercant C; Lliteras E; Cózar M; Girona-Llobera E
Transfus Apher Sci; 2015 Feb; 52(1):84-93. PubMed ID: 25554212
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
Wagner SJ; Seetharaman S; Kurtz J
Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
[TBL] [Abstract][Full Text] [Related]
25. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
26. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B; Alberio L; Rochat S; Stenner F; Manz MG; Buser A; Schanz U; Stussi G
Transfusion; 2016 Oct; 56(10):2426-2437. PubMed ID: 27339466
[TBL] [Abstract][Full Text] [Related]
28. Routine bacterial screening of apheresis platelets on Day 4 using a rapid test: a 4-year single-center experience.
Dunbar NM; Kreuter JD; Marx-Wood CR; Dumont LJ; Szczepiorkowski ZM
Transfusion; 2013 Oct; 53(10):2307-13. PubMed ID: 23347110
[TBL] [Abstract][Full Text] [Related]
29. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
31. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of autologous platelet transfusion in cardiac surgery: comparison of cryopreservation, blood collection on the day before surgery, and blood collection during surgery.
Yokomuro M; Ebine K; Shiroma K; Tamura S; Kumabe S; Ohtuki M; Suzuki H; Uchida S
Cryobiology; 1999 May; 38(3):236-42. PubMed ID: 10328913
[TBL] [Abstract][Full Text] [Related]
33. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
[TBL] [Abstract][Full Text] [Related]
34. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
35. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
36. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
Katz L; Palmer K; McDonnell E; Kabat A
Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
[TBL] [Abstract][Full Text] [Related]
37. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
Heuft HG; Moog R; Fischer EG; Zingsem J;
Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
[TBL] [Abstract][Full Text] [Related]
38. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
[TBL] [Abstract][Full Text] [Related]
39. Viability and function of 8-day-stored apheresis platelets.
Slichter SJ; Bolgiano D; Jones MK; Christoffel T; Corson J; Rose L; Foley J; Popovsky M; Baril LL; Corda T; Dincecco DM; Snyder EL
Transfusion; 2006 Oct; 46(10):1763-9. PubMed ID: 17002633
[TBL] [Abstract][Full Text] [Related]
40. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
Méndez A; Wägli F; Schmid I; Frey BM
Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
